NEW DELHI:
Bharat Biotech on Thursday announced a cut in price of its COVID-19 vaccine ”Covaxin” it plans to sell to the states to Rs 400 per dose from the earlier Rs 600.
This follows a widespread criticism of its pricing policy as it sold Covaxin to the central government at Rs 150 per dose.
“Recognising the enormous challenges in the public healthcare system, we have made Covaxin available to state governments at a price of 400/ dose”, Bharat Biotech said in its announcement.
The company is deeply concerned with the critical pandemic circumstances that India is facing at this time, it added.
Serum Institute of India (SII) had on Wednesday slashed the price of its COVID-19 vaccine ”Covishield” to Rs 300 per dose from the earlier Rs 400 for state governments.
more recommended stories
KOCHI:The Physical Medicine and Rehabilitation (PMR).
MUMBAI:Every mother remembers the magic of.
PATNA:A woman teacher was allegedly shot.
കൊച്ചി : കുട്ടികളിൽ കാണപ്പെടുന്ന പ്രധാന വാസ്കുലൈറ്റിസുകളില്.
NATIONAL: Jos Alukkas, a trusted name in.
THIRUVANANTHAPURAM: Doctors at KIMSHEALTH successfully corrected.
കൊച്ചി: സാംസങ് പുതിയ സൂപ്പര്–പ്രീമിയം ആര്20 അള്ട്രാസൗണ്ട്.
GURUGRAM: Samsung, India’s largest consumer electronics.
കൊച്ചി : ആന്റിമൈക്രോബിയൽ റെസിസ്റ്റൻസ് (AMR) എന്ന.
KOCHI: Amrita Hospital observed World Antimicrobial.
